Who Paid My Doc
iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study
Research payments
$636,817
Through program year 2025, $636,817 in research payments was reported against iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study, across 357 payments, paid by Glaukos Corporation.
- Paid by
- Glaukos Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $146,372 | 124 |
| 2024 | Research | $490,445 | 233 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- John Berdahl Sioux Falls, SD Named on 37 payments
- Russell Swan Bozeman, MT Named on 24 payments
- Davinder Grover Dallas, TX Named on 22 payments
- Steven Sarkisian Oklahoma City, OK Named on 20 payments
- Benjamin Heller Phoenix, AZ Named on 20 payments
- Deborah Ristvedt Alexandria, MN Named on 20 payments
- Damien Goldberg Torrance, CA Named on 18 payments
- Gang Hu Hurst, TX Named on 18 payments
- Michael Greenwood West Fargo, ND Named on 17 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.